Stay updated on Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Locations section now includes a comprehensive list of participating sites by state and country (US states, Australia, United Kingdom, etc.). The previous location blocks (e.g., Alabama Locations, California Locations) were replaced under revision v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T09:10:38.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2. No substantive study details appear to have changed.
    Difference
    0.0%
    Check dated 2025-12-01T16:37:46.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and updated the revision to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T11:36:48.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Removed the general operating-status notice about funding lapse and NIH operations, which is not part of the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T06:14:58.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The new screenshot shows minor UI/layout adjustments on the study details page with no changes to core content such as the study title, eligibility criteria, or trial arms. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T00:48:21.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T05:05:55.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Bevacizumab in Glioblastoma Clinical Trial page.